Biomerica, Inc. (BMRA) Financials

BMRA Assets vs Liabilities

DateAssetsLiabilities
2023-11-30 11.8 million 2.4 million
2023-08-31 13.2 million 2.5 million
2023-05-31 14.5 million 2.7 million
2023-02-28 8.2 million 2.2 million

BMRA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-11-30 -854000 122000
2023-08-31 -1.7 million 170000
2023-05-31 -976817 179187
2023-02-28 -1.7 million 383828

BMRA Net Income

No data available :(

BMRA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-11-30 7.1 million - 937000
2023-08-31 8.0 million - 1.0 million
2023-05-31 9.7 million - 1.1 million
2023-02-28 3.3 million - 1.2 million

BMRA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-11-30 16.8 million
2023-08-31 16.8 million
2023-05-31 16.6 million
2023-02-28 13.5 million

BMRA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-11-30 12000 412000 1.5 million -
2023-08-31 63000 472000 1.2 million -
2023-05-31 14140 368857 1.5 million -
2023-02-28 5762 392031 1.4 million -

BMRA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-11-30 1.6 million 1.2 million
2023-08-31 1.7 million 1.3 million
2023-05-31 1.1 million 1.1 million
2023-02-28 1.1 million 991169

BMRA

Price: $0.53

52 week price:
0.53
2.13

Earnings Per Share: -0.38 USD

P/E Ratio: -2.61

Exchange: NCM

Sector: Healthcare

Industry: Medical Devices

Volume: 8300

Ebitda: -223324

Market Capitalization: 13.9 million

Links: